Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H6MC
|
|||
| Former ID |
DNC002841
|
|||
| Drug Name |
3h-Indole-5,6-Diol
|
|||
| Synonyms |
5,6-Dihydroxyindole; 3131-52-0; 1H-Indole-5,6-diol; Dopamine lutine; 3H-INDOLE-5,6-DIOL; dhi; UNII-Z3OC8499KG; 5,6-DihydroxyindoleI; C8H7NO2; CHEMBL92636; Z3OC8499KG; CHEBI:27404; AK-25753; D-3560; 3ID; 5,6-Dihydroxy-1H-indole; indole-5,6-diol; 5,6-dihydroxy indole; AC1L3FSK; EC 412-130-9; SCHEMBL48994; AC1Q7A19; CTK1C3371; DTXSID20185242; SGNZYJXNUURYCH-UHFFFAOYSA-N; MolPort-001-782-232; ZINC895800; BCP02562; ACT06797; EBD26988; ZX-AT011826; KS-00000J9K; CD-595; BDBM50028548; BBL102959; ANW-44822; STL556768; MFCD00798933; FCH834612
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H7NO2
|
|||
| Canonical SMILES |
C1=CNC2=CC(=C(C=C21)O)O
|
|||
| InChI |
1S/C8H7NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h1-4,9-11H
|
|||
| InChIKey |
SGNZYJXNUURYCH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 3131-52-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
7904, 829063, 3191510, 6590040, 7885279, 8144519, 10236450, 15170871, 22388970, 29296344, 32604828, 46508625, 49747293, 50064672, 50415780, 57338761, 57390338, 61013403, 84941448, 88825216, 99373876, 103100573, 103301769, 103937770, 104396641, 117616528, 125368595, 126524986, 126556688, 126577267, 126598396, 126629312, 126646248, 126735138, 127719587, 129096223, 129233010, 131541452, 135069683, 135604824, 136341478, 137003311, 137184402, 142389040, 152223102, 160812320, 160965038, 162109545, 162147001, 162516702
|
|||
| ChEBI ID |
CHEBI:27404
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lactotransferrin (LTF) | Target Info | Inhibitor | [1] |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| TCR Signaling Pathway | ||||
| Reactome | ROS production in response to bacteria | |||
| Amyloid formation | ||||
| WikiPathways | Latent infection of Homo sapiens with Mycobacterium tuberculosis | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.